Category

Bioscience and medicine

Trailblazing Training Adds to Chemistry’s Attraction

By | Advanced materials, Bioscience and medicine, Innovation and infrastructure, Just Added | No Comments
When designing new molecules for pharmaceutical and other uses, the key is to combine the right elements in the right way. The same is true of the training vital to nurturing the skills needed to make it happen.     A perfect example has seen Southampton University join forces with Oxford and Bristol to establish an EPSRC Centre for Doctoral Training (CDT) integrating two vital aspects of chemistry in a powerful new way. With strong links to industry ensuring its work feeds into the real economy, the Theory and Modelling in Chemical Sciences (TMCS) CDT is producing tomorrow’s research leaders and equipping...
Read More

Making the Structure of Materials Crystal Clear

By | Advanced materials, Bioscience and medicine, Energy and climate change | No Comments
Exposing the deepest, most revealing secrets of materials’ structure is all part of a day’s work at the UK National Crystallography Service (NCS), based at the University of Southampton. By firing X-ray beams at crystals often just one-hundredth the size of a salt grain and then measuring the radiation’s diffraction pattern, Professor Simon Coles and his team generate important insights into materials and their properties – facilitating development of, for example, new drugs and novel energy storage technologies. This cutting-edge service provides UK academia and industry with easy access to world-class crystallography skills and facilities, opening the door to discovery...
Read More

Reassessing Asthma: Biomarkers, Business and Big Data

By | Bioscience and medicine, Just Added, The Data Revolution | No Comments
Affecting millions and costing billions worldwide every year, asthma needs to be better understood to enable better treatment and management of this frequently distressing, sometimes fatal family of respiratory diseases. With SES members Southampton University and Imperial College London at the heart of its conception and execution, the multi-million-Euro U-BIOPRED project – the world’s biggest collaboration in severe asthma – is driving discoveries that will improve targeting of drugs and equip pharma businesses to develop potentially game-changing new ones. Above all, in pinpointing key ‘biomarkers’ – molecules revealing the precise type of asthma present in patients – U-BIOPRED has produced...
Read More

Material Progress – and How to Achieve It

By | Advanced materials, Bioscience and medicine, Energy and climate change, Popular | No Comments
In every sense, we live in a material world and the drive to develop smarter, lighter, more versatile and resilient materials shows no sign of decelerating. Whether designed to withstand brutal operating environments, save energy or bring life-saving medical advances within reach, there’s a constant thirst for the next generation of game-changers – and the UCL Institute for Materials Discovery (IMD) is delivering the innovation, imagination and inspiration needed to succeed. Under its Director, Professor Kwang-Leong Choy, and with a growing network of collaborators – including other SES members plus partners worldwide – the IMD is already an established institute...
Read More

How to Improve Your Image

By | Bioscience and medicine, Just Added | No Comments
From screening unborn babies to combating cancer, the need to make medical imaging ever more effective goes to the heart of the never-ending drive to pioneer new possibilities in healthcare. At King’s College London (KCL), the Division of Imaging Sciences and Biomedical Engineering, led by Professor Reza Razavi, is dedicated to the development and rapid application of imaging and computational modelling techniques capable of delivering advances in this field. To this end, the Division relentlessly reaches out to fellow SES members and to industry, healthcare providers and academic institutions to forge powerful collaborations that create new capabilities – boosting clinical...
Read More

From London Labs to Global Growth: the Abzena Story

By | Bioscience and medicine | No Comments
Successful university spinout companies are a key feature of the UK’s economic landscape – but not many can match the remarkable rise of Abzena, a thriving life sciences business at the arrow tip of medical innovation. From its origins in cross-institutional research at the London School of Pharmacy (now part of UCL) and Imperial College London, to the launch of spinout PolyTherics and its evolution into Abzena, this is a story of how great science and commercial vision have led to new therapies targeting cancer, macular degeneration and other serious conditions. But this is also a tale where close, mutually...
Read More

Meeting the Needs of a Wireless World

By | Bioscience and medicine, Cities and supporting life, Innovation and infrastructure, Technology and interconnectivity | No Comments
It’s hard to deny how much we depend on wireless communications – and one pace-setting spinout company is helping to make it possible through patented technology developed at UCL and Cambridge University. From schools, hospitals, airports and shopping malls, to sports stadia, music arenas, power stations and corporate HQs, Zinwave delivers unique optical-fibre solutions that allow high-quality wireless coverage to reach every part of a building or complex – however big it is, however tall it is and however far it extends underground. Zinwave’s success demonstrates not just how collaboration between academic institutions can lead to remarkable technical breakthroughs, but...
Read More

How HPC is Boosting Cutting-Edge Biology

By | Bioscience and medicine, Recommended, The Data Revolution | No Comments
High Performance Computing (HPC) is adding momentum to the evolution of biological science and a revolution in our understanding of how biological systems function – as pioneering research at UCL is clearly demonstrating. To drive their work forward, Dr Chris Barnes and his Computational Systems and Synthetic Biology Group make extensive use of large HPC systems, especially Emerald, the SES GPU-accelerated supercomputer, established using funding from the Engineering and Physical Sciences Research Council (EPSRC) . The group is at the leading edge of the fast-developing field of quantitative biology, a discipline that uses measurable data and mathematical modelling to reveal...
Read More

What is CFD with Dr. Peter Vincent

By | Bioscience and medicine, Energy and climate change, Innovation and infrastructure, Technology and interconnectivity, Uncategorised | No Comments

We sat down with Dr. Peter Vincent to gain some insight into his research at Vincent Lab (www.imperial.ac.uk/aeronautics/research/vincentlab/). Dr. Vincent has been a key user of SES machine Emerald, and discusses here the impacts of CFD research, from medical applications to renewable energy and Aeronautical Engineering. To find out more about his research, read the case study. Stay tuned for Part two, and don’t forget to subscribe.

Read More